A new generation of implantable electrodes
Therapeutic outcomes from clinical neural implants are limited by their mechanical properties. Their stiff and rigid designs present a mechanical mismatch compared to the soft and curved tissues they interface with, thereby constraining the physiological motion dynamics of the nervous system.
At Neurosoft Bioelectronics, we are addressing this issue by engineering elasticity in thin film materials to manufacture implantable electrodes that are much softer and flexible, and that can seamlessly interface with the nervous system.
Latest News
Neurosoft Bioelectronics selected by Bilan as one of the best Swiss Startups to invest in
During the 9th edition of “Les Meilleures startups ” (Best Startups), organized by the Swiss magazine Bilan, Neurosoft Bioelectronics was selected as one of the most promising startups to invest in. This year 31 startups were chosen out of 88 applicants coming from...
Neurosoft Bioelectronics is one of the 5 Prix Strategis finalists
We are proud to announce that Neurosoft Bioelectronics has been selected as one of the 5 finalists competing for the Prix Strategis 2021. In the final stage we will have the chance to pitch to the Jury, who will select the winning startup, to be announced on May 12th....
Breakthrough SOFT ECoG™ technology published in Advanced Science
A new study led by Dr. Florian Fallegger (CTO of Neurosoft Bioelectronics) has been recently published in Advanced Science, highlighting the promising potential of our soft technology for the development of neural implants in clinical settings. Neural implants can be...
Supported by
